In the field of biopharmaceuticals, immunogenicity refers to the ability of a drug to induce an immune response in a patient This response can range from the development of neutralizing antibodies to severe allergic reactions Therefore, it is essential to assess the immunogenic potential of a drug during its development and post-market surveillance, to ensure its safety and efficacy.
Immunogenicity assays play a crucial role in this process, as they are used to measure the presence and impact of drug-induced immune responses immunogenicity assay development validation and implementation. These assays can detect the production of antibodies against the drug or its components, as well as measure the strength of the immune response Developing, validating, and implementing these assays is essential in ensuring the accuracy and reliability of the results obtained.
Developing Immunogenicity Assays